Tolochenaz

Spasticity Affects a Significant Number of Post-Stroke Patients, [1],[2],[3] and Many are not Adequately Treated by Standard Therapy [4]

World’s First Deep Brain Stimulation Device Approved for Treatment of Psychiatric Condition in Europe

TOLOCHENAZ, Switzerland, March 23, 2010 - Medtronic, Inc.

Older News

TOLOCHENAZ, Switzerland - - CE Mark Approval for Medtronic's Reclaim(R) DBS Therapy for Treatment of Chronic, Severe Obsessive-Compulsive Disorder Medtronic today announced that Reclaim(R) Deep Brain Stimulation (DBS) Therapy has received CE (Conformite Europeene) Mark approval for the treatment of chronic, severe treatment-resistant obsessive-compulsive disorder (OCD).* This is the first time that a deep brain stimulation therapy has gained approval in Europe for the treatment of a psychiatric disorder.

MORE..